Comparative Outcomes of Four Versus Two Balloon Inflation Points in Dacryoplasty for Primary Acquired Nasolacrimal Duct Obstruction
Recruiting now · Not applicable
Conditions studied: Primary Acquired Nasolacrimal Duct Obstruction
In brief
Primary acquired nasolacrimal duct obstruction
Key facts
- Study ID
- NCT07225244
- Run by
- National Taiwan University Hospital
- People needed
- 50
- Starts
- 2025-11-01
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2025-11-06
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnosed with primary acquired nasolacrimal duct obstruction (PANDO)
You may not qualify if…
- Patients who are pregnant, with previous lacrimal procedure, upper lacrimal drainage obstruction, punctal stenosis, active dacryocystitis, dacryolithiasis, traumatic obstruction or lacrimal mass
Where it is running
- National Taiwan University Hospital — Taipei, Taiwan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.